NEW YORK — Innovative Health Diagnostics said on Tuesday that it has partnered with Ontario-based AIMA Laboratories to develop a microRNA-based at-home test for endometriosis.
According to Innovative Health, the test detects miRNA biomarkers that are differentially expressed in women with endometriosis compared to women without the disease. Patients who receive a positive result from the blood test will be recommended for a laparoscopy, the Irvine, California-based company said.
Additional terms of the alliance were not disclosed.